Literature DB >> 16756741

Estimating blood volume in obese and morbidly obese patients.

Harry J M Lemmens1, Donald P Bernstein, Jay B Brodsky.   

Abstract

Preoperative assessment of blood volume (BV) is important for patients undergoing surgery. The mean value for indexed blood volume ((In)BV) in normal weight adults is 70 mL/kg. Since (In)BV decreases in a non-linear manner with increasing weight, this value cannot be used for obese and morbidly obese patients. We present an equation that allows estimation of (In)BV over the entire range of body weights.

Entities:  

Mesh：

Year:  2006        PMID： 16756741     DOI： 10.1381/096089206777346673

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


  45 in total

1.  Anti-Xa Levels 4 h After Subcutaneous Administration of 5,700 IU Nadroparin Strongly Correlate with Lean Body Weight in Morbidly Obese Patients.

Authors:  Jeroen Diepstraten; Christian M Hackeng; Simone van Kralingen; Jiri Zapletal; Eric P A van Dongen; René J Wiezer; Bert van Ramshorst; Catherijne A J Knibbe
Journal:  Obes Surg       Date:  2012-02-01       Impact factor: 4.129

2.  Therapeutic Enoxaparin in the Morbidly Obese Patient: A Case Report and Review of the Literature.

Authors:  Claudia M Hanni; Sheila M Wilhelm; Bianca Korkis; Elizabeth A Petrovitch; Kanella V Tsilimingras; Sean M McConachie
Journal:  Hosp Pharm       Date:  2018-09-22

Review 3.  Designing drug regimens for special intensive care unit populations.

Authors:  Brian L Erstad
Journal:  World J Crit Care Med       Date:  2015-05-04

Review 4.  A Review of the Toxicologic Implications of Obesity.

Authors:  Matthew Zuckerman; Howard A Greller; Kavita M Babu
Journal:  J Med Toxicol       Date:  2015-09

5.  Adjusted versus actual body weight dosing of 4-factor prothrombin complex concentrate in obese patients with warfarin-associated major bleeding.

Authors:  Keaton S Smetana; Rachel Ziemba; Casey C May; Michael J Erdman; Edward T Van Matre; G Morgan Jones
Journal:  J Thromb Thrombolysis       Date:  2019-04       Impact factor: 2.300

6.  Impact of clinical factors and UGT1A9 and CYP2B6 genotype on inter-individual differences in propofol pharmacokinetics.

Authors:  Akihiro Kanaya; Toshihiro Sato; Nobuo Fuse; Hiroaki Yamaguchi; Nariyasu Mano; Masanori Yamauchi
Journal:  J Anesth       Date:  2018-02-21       Impact factor: 2.078

7.  The effect of obesity and repeated exposure on pharmacokinetic response to grape polyphenols in humans.

Authors:  Janet A Novotny; Tzu-Ying Chen; Anton I Terekhov; Sarah K Gebauer; David J Baer; Lap Ho; Giulio M Pasinetti; Mario G Ferruzzi
Journal:  Mol Nutr Food Res       Date:  2017-08-29       Impact factor: 5.914

8.  Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome.

Authors:  Emily S Jungheim; Susan E Lanzendorf; Randall R Odem; Kelle H Moley; Aimee S Chang; Valerie S Ratts
Journal:  Fertil Steril       Date:  2008-08-09       Impact factor: 7.329

Review 9.  Physiological and management implications of obesity in critical illness.

Authors:  Michael G S Shashaty; Renee D Stapleton
Journal:  Ann Am Thorac Soc       Date:  2014-10

10.  Dose correction for post-contrast T1 mapping of the heart: the MESA study.

Authors:  Neville D Gai; Veit Sandfort; Songtao Liu; João A C Lima; David A Bluemke
Journal:  Int J Cardiovasc Imaging       Date:  2015-09-11       Impact factor: 2.357
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.